{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T03:48:40Z","timestamp":1649130520824},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.rce.2011.05.018","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T00:01:38Z","timestamp":1326153698000},"page":"115-117","source":"Crossref","is-referenced-by-count":0,"title":["Pulpitis seca y fisuras en los dedos de las manos en pacientes que reciben tratamiento combinado para hepatitis C"],"prefix":"10.1016","volume":"212","author":[{"given":"F.","family":"Jover-D\u00edaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Cuadrado-Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.R.","family":"Gallardo-Quesada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rce.2011.05.018_bib0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.rce.2010.05.026","article-title":"Interfer\u00f3n alfa y virus hepatitis C: la piel importa","volume":"211","author":"Florist\u00e1n","year":"2011","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rce.2011.05.018_bib0010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1155\/2009\/651952","article-title":"A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin","volume":"23","author":"Mistry","year":"2009","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.rce.2011.05.018_bib0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa 2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2011.05.018_bib0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gut.2006.102558","article-title":"A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C","volume":"56","author":"Yu","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.rce.2011.05.018_bib0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1470-2045(05)70243-6","article-title":"Cutaneous side-effects of kinase inhibitors and blocking antibodies","volume":"6","author":"Robert","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.rce.2011.05.018_bib0030","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/annonc\/mdi279","article-title":"Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors","volume":"16","author":"Segaert","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rce.2011.05.018_bib0035","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1365-2133.2001.04226.x","article-title":"Cutaneous side-effects in patients treated with the antiepidermal growth factor receptor antibody C225","volume":"144","author":"Busam","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rce.2011.05.018_bib0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2133.1986.tb02817.x","article-title":"Effect of recombinant alpha A-interferon on DNA synthesis and differentiation of human keratinocytes in vitro","volume":"114","author":"Stadler","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rce.2011.05.018_bib0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/1523-1747.ep12275353","article-title":"Effects of alpha and beta interferons on cultured human keratinocytes","volume":"85","author":"Yaar","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.rce.2011.05.018_bib0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0531-5565(89)90048-X","article-title":"Interferon and the epidermis: implications for cellular senescence","volume":"24","author":"Peacocke","year":"1989","journal-title":"Exp Gerontol"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256511003523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256511003523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T01:26:50Z","timestamp":1543282010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256511003523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0014256511003523"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2011.05.018","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}